Armen Panossian

Insider Reports History

Reporting-owner location: Los Angeles, CA
Latest reporting-owner signature: /s/ Mary Gallegly, attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Armen Panossian

Form 4 holding Chief Executive Officer and Co-Chief Investment Officer

Oaktree Specialty Lending Corp

Security class: Common Stock, par value $0.01 per share
Shares / value: 22,489
Estimated value: $285,486
Report date: 12 Aug 2026
Price: $12.69
Ownership: Direct

Insider Reports Filed by Armen Panossian

4 OCSL

Oaktree Specialty Lending Corp

Report period: 12 Aug 2026
Transactions: 1
Transaction value: +$21,581
Accepted by SEC: 13 Aug 2026, 16:05
Role: Chief Executive Officer and Co-Chief Investment Officer
Next action: Open filing details

4 OCSL

Oaktree Specialty Lending Corp

Report period: 07 May 2025
Transactions: 1
Transaction value: +$113,040
Accepted by SEC: 19 May 2025, 06:06
Role: Chief Executive Officer and Co-Chief Investment Officer
Next action: Open filing details

3

Oaktree Strategic Credit Fund

Report period: 03 Feb 2022
Transactions: 0
Transaction value: $0
Accepted by SEC: 03 Feb 2022, 15:16
Role: Chief Executive Officer, Trustee
Next action: Open filing details

3

Oaktree Diversified Income Fund Inc.

Report period: 29 Oct 2021
Transactions: 0
Transaction value: $0
Accepted by SEC: 08 Nov 2021, 20:54
Role: PORTFOLIO MANAGER
Next action: Open filing details

3

Oaktree Diversified Income Fund Inc.

Report period: 29 Oct 2021
Transactions: 0
Transaction value: $0
Accepted by SEC: 08 Nov 2021, 20:54
Role: PORTFOLIO MANAGER
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .